Standard BioTools Reports Q3 Loss, Projects $165M-$175M Revenue
Update: 2025-11-04
Description
Standard BioTools Incorporated reports a Q3 loss of $34.7M, or $0.09 per share, with adjusted losses at $0.04 per share. Despite the loss, the company saw $19.6M in revenue. Looking ahead, they project full-year revenue between $165M and $175M.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
